Among the two patients with breast cancer who achieved SD, one harbored an Akt1E17K mutation with a CDH1 frameshift deletion and another harbored a PIK3CA H1047R mutation with a KRAS missense mutation. This evidence concerns the gene KRAS and breast carcinoma.